413 Phase II study evaluating the efficacy, safety and pharmacodynamic correlative study of dual anti-angiogenic inhibition using Bevacizumab (B) in combination with Sorafenib (S) in patients (pts) with advanced malignant melanoma

✍ Scribed by D. Mahalingam; M. Beeram; J. Rodon; K. Sankhala; A. Mita; D. Benjamin; J. Michalek; A. Tolcher; J. Wright; J. Sarantopoulos

• Book ID: 119603096
• Publisher: Elsevier Science
• Year: 2010
• Tongue: English
• Weight: 48 KB
• Volume: 8
• Category: Article
• ISSN: 1359-6349
• DOI: 10.1016/s1359-6349(10)72120-0